Genewiz, LLC

South Plainfield, NJ Part of Azenta, Inc.

UEI
HAYFEH7AD428
CAGE
3XDT5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
115 Corporate Blvd, South Plainfield, NJ 07080, USA
Website
genewiz.com
Founded
1999
Employees
1K-5K
Estimated annual revenue
$500M-$1B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$66,723
FY2025 -$33,814
FY2024 -$73,211
FY2023 $383,124

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Genewiz, LLC is a global contract research organization specializing in genomic services such as gene synthesis, next generation sequencing, Sanger sequencing, and bioinformatics. As a subsidiary of Azenta, Inc., which does business as Brooks, Genewiz provides precision genomic analysis capabilities and solutions for life sciences research.

Through past federal contract awards, Genewiz has provided DNA and RNA sequencing services, primarily on Illumina platforms, to support research initiatives at agencies including the National Institutes of Health (NIH), National Cancer Institute (NCI), Department of Veterans Affairs (VA), and United States Geological Survey (USGS). Specific services have encompassed whole genome, whole exome, transcriptome, and single cell sequencing, as well as PCR, library preparation, data analysis, and sample processing. Genewiz has also delivered gene synthesis, cloning, variant development, and immunoprofiling services under federal contracts with no set-aside designations. Work has been performed as a prime contractor directly for federal customers as well as a subcontractor under larger research programs.

Genewiz holds several federal Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicles which provide next generation sequencing, RNA analysis, molecular biology services, and other genomic capabilities to federal agencies. These include a 5 year IDIQ from the NIH National Institute of Environmental Health Sciences for DNA sequencing, a NCI Genomic Characterization Centers IDIQ encompassing cancer genomics, a VA IDIQ for molecular biology services, and IDVs with the USGS to support microbiome, biodiversity, and environmental DNA sequencing in conjunction with internal research objectives. Task orders under these vehicles have enabled Genewiz to provide specialized genomic services utilizing its technical expertise to further the mission of federal agencies through scientific initiatives and health research programs.

Quick answers

Is Genewiz, LLC registered in SAM.gov?

Genewiz, LLC's SAM.gov registration expired on April 29, 2026.

Which contract vehicles does Genewiz, LLC hold?

Genewiz, LLC holds a place on 1 federal contract vehicle: NCI Genomic Characterization Centers.

How much has Genewiz, LLC received in federal contracts?

Federal contracts obligated $209,376 to Genewiz, LLC in fiscal years 2023 through 2027.

What is Genewiz, LLC's most recent federal award?

Genewiz, LLC's most recent federal contract award is Genewiz - 12 months of funding (75N96023F00002), from National Institute of Environmental Health Sciences (NIH), on September 15, 2023.

On GovTribe

See Genewiz, LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors